Skip to main
AMTX
AMTX logo

Aemetis (AMTX) Stock Forecast & Price Target

Aemetis (AMTX) Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 13%
Sell 13%
Strong Sell 0%

Bulls say

Aemetis Inc. is positioned for significant revenue growth, with projections indicating an increase from $398 million in 2025 to $1.8 billion by 2036, reflecting a compound annual growth rate (CAGR) of approximately 14.4%. The company’s operational execution is strong, with promising catalysts such as new contracts in India and potential cash flows from its renewable natural gas (RNG) business, along with an anticipated IPO of its biodiesel segment in 2025, which could enhance its balance sheet. Additionally, despite expected increases in operating expenses at an 8.9% annual CAGR, the current share price presents a favorable entry point for investors looking for upside potential.

Bears say

Aemetis Inc. experienced a significant decline in revenue from its India operations, falling from $32 million in Q3 2024 to just $3 million in Q4 2024, indicating potential operational challenges in the region. The company reported a net loss of $16.2 million for Q4 2024, a slight improvement from a net loss of $25.4 million in the same quarter of the previous year, but still reflecting ongoing financial struggles. Additionally, the earnings per share of $(0.36) for Q4 2024 were worse than the company's own estimate and not far from consensus expectations, suggesting continued difficulty in achieving profitability amid fluctuating revenues.

Aemetis (AMTX) has been analyzed by 8 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 13% suggest Holding, 13% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aemetis and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aemetis (AMTX) Forecast

Analysts have given Aemetis (AMTX) a Buy based on their latest research and market trends.

According to 8 analysts, Aemetis (AMTX) has a Buy consensus rating as of Sep 9, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $14.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $14.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aemetis (AMTX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.